Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases

  title={Nanosuspensions: a new approach for organ and cellular targeting in infectious diseases},
  author={Shegokar Ranjita},
  journal={Journal of Pharmaceutical Investigation},
Most of the infectious diseases depending upon the stage of infection need treatment at least for a month to several years e.g. tuberculosis, acquired immunodeficiency syndrome. Medication by oral administration is of choice in all treatments, but unfortunately use of large doses resulting from drug poor solubility and bioavailability leads to toxicity. The problem of solubility should be solved in easiest way to reduce dose and to increase bioavailability thereby decreasing the unnecessary… CONTINUE READING


Publications citing this paper.


Publications referenced by this paper.
Showing 1-10 of 155 references

Nevirapine nanosuspension: comparative investigation of production methods

R Shegokar, KK Singh, RH Müller
Nanotechnol Dev • 2011
View 4 Excerpts
Highly Influenced

Present status of nanoparticle research for treatment of tuberculosis

R Shegokar, L Al Shaal, K Mitri
J Pharm Pharm Sci • 2011
View 4 Excerpts
Highly Influenced

Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension.

International journal of pharmaceutics • 2010
View 2 Excerpts
Highly Influenced

Itraconazole nanosuspension for oral delivery: Formulation, characterization and in vitro comparison with marketed formulation

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences • 2010
View 3 Excerpts
Highly Influenced

Chagas disease: a Latin American nemesis

AM Strosberg, K Barrio, +4 authors K Woo
View 1 Excerpt
Highly Influenced

Similar Papers

Loading similar papers…